PubMed:33338232 / 441-596
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 40 | 0-8 | Species | denotes | Patients | Tax:9606 |
| 41 | 56-78 | Chemical | denotes | sofosbuvir/daclatasvir | |
| 42 | 84-102 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 43 | 130-148 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 0-155 | Sentence | denotes | Patients were randomized into a treatment arm receiving sofosbuvir/daclatasvir plus hydroxychloroquine or a control arm receiving hydroxychloroquine alone. |